Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0Y2HH
|
|||
| Former ID |
DCL000142
|
|||
| Drug Name |
KC706
|
|||
| Indication | Cardiovascular disease [ICD-11: BA00-BE2Z] | Discontinued in Phase 2 | [1] | |
| Inflammatory bowel disease [ICD-11: DD72; ICD-10: K52.3] | Discontinued in Phase 2 | [1] | ||
| Psoriasis vulgaris [ICD-11: EA90] | Discontinued in Phase 2 | [1] | ||
| Rheumatoid arthritis [ICD-11: FA20] | Discontinued in Phase 2 | [1] | ||
| Company |
Kemia
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800023346) | |||
| REF 2 | KC706, an Oral p38 MAP Kinase Inhibitor, Increases HDL-C. Circulation. 2007;116:II_126. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.